LONDON: PureTech Health plc has filed a public Registration Statement on Form 20-F to the United States Securities and Exchange Commission (SEC) in conjunction with a potential listing of American Depository Shares (ADSs) on the Nasdaq Stock Market. The U.S. Listing is expected to take place after the SEC and Nasdaq have completed their review…
All posts tagged Nasdaq Global Market
Tarsus Pharmaceuticals prices $88 million IPO on Nasdaq Global Market
LONDON: RTW Venture Fund Limited’s portfolio company Tarsus Pharmaceuticals Inc. has priced an $88 million initial public offering (IPO) and admission to trade on Nasdaq Global Market under the ticker “TARS”. Tarsus’ IPO was significantly upsized and oversubscribed, raising $88 million, offering 5.5 million shares at $16.00 per share. On the first day of trading,…
Abcam announces offering and application to list on Nasdaq Global Market
LONDON: Abcam plc announced today the commencement of a registered offering of 8,945,218 American Depositary Shares (ADSs). Each ADS offered represents one ordinary share of Abcam. The ADSs are being offered in a registered public offering in the United States. All ADSs to be sold in the Offering will be sold by Abcam. In addition,…